Allan R. Wang

Allan R. Wang

Auto-generated profile, based on publicly available information

Allan R. Wang

Department of Otolaryngology–Head and Neck Surgery David Geffen School of Medicine at the University of California at Los Angeles Los Angeles California USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2023 in Nature
Verified
Journal Article
Open access
PDF file
DBDaniel A. N. Barbosa
Daniel A. N. Barbosa
SGSandra Gattas
Sandra Gattas
JSJuliana S. Salgado
Juliana S. Salgado
FKFiene Marie Kuijper
Fiene Marie Kuijper
AWAllan R. Wang
Allan R. Wang
CHCasey H. Halpern
Casey H. Halpern
Only recently have more specific circuit-probing techniques become available to inform previous reports implicating the rodent hippocampus in orexigenic appetitive processing1–4. This function has been reported to be mediated at least in part by lateral hypothalamic inputs, including those involving orexigenic lateral hypothalamic neuropeptides, such as melanin-concentrating hormone5,6. This circuit, however, remains elusive in humans. Here we combine tractography, intracranial electrophysiology, cortico-subcortical evoked potentials, and brain-clearing 3D histology to identify an orexigenic circuit involving the lateral hypothalamus and converging in a hippocampal subregion. We found that low-frequency power is modulated by sweet-fat food cues, and this modulation was specific to the dorsolateral hippocampus. Structural and functional analyses of this circuit in a human cohort exhibiting dysregulated eating behaviour revealed connectivity that was inversely related to body mass index. Collectively, this multimodal approach describes an orexigenic subnetwork within the human hippocampus implicated in obesity and related eating disorders.

1 December 2019 in Cortex
Verified
Journal Article
Closed access
BBBorna Bonakdarpour
Borna Bonakdarpour
RHRobert S. Hurley
Robert S. Hurley
AWAllan R. Wang
Allan R. Wang
HFHernando R. Fereira
Hernando R. Fereira
ABAnisha Basu
Anisha Basu
MMM. Marsel Mesulam
M. Marsel Mesulam

1 April 2017 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Closed access
BBBorna Bonakdarpour
Borna Bonakdarpour
EREmily J. Rogalski
Emily J. Rogalski
AWAllan Wang
Allan Wang
JSJaiashre Sridhar
Jaiashre Sridhar
MMM.M. Mesulam
M.M. Mesulam
RHRobert S. Hurley
Robert S. Hurley
Primary progressive aphasia (PPA) is a clinical syndrome of language decline caused by neurodegenerative pathology. Although language impairments in PPA are typically localized via the morphometric assessment of atrophy, functional changes may accompany or even precede detectable structural alterations, in which case resting state functional connectivity (RSFC) could provide an alternative approach. The goal of this study was to determine whether language network RSFC is reduced in early-stage PPA when atrophy is not prominent. We identified 10 individuals with early-stage agrammatic variant of PPA with no prominent cortical thinning compared with nonaphasic controls. RSFC between 2 nodes of the language network and 2 nodes of the default mode network were compared between agrammatic variant of PPA and healthy control participants. Language network connectivity was comparable with controls among patients with milder agrammatism, but was significantly reduced in patients with more pronounced agrammatism. No group differences were observed in default mode network connectivity, demonstrating specificity of findings. In early stages of PPA when cortical atrophy is not prominent, RSFC provides an alternative method for probing the neuroanatomic substrates of language impairment. RSFC may be of particular utility in studies on early interventions for neurodegenerative disease, either to identify anatomic targets for intervention or as an outcome measure of therapeutic efficacy.

29 March 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
AWAllan R. Wang
Allan R. Wang
FKFiene Marie Kuijper
Fiene Marie Kuijper
DBDaniel A. N. Barbosa
Daniel A. N. Barbosa
KHKelsey Hagan
Kelsey Hagan
ELEric Lee
Eric Lee
CHCasey H. Halpern
Casey H. Halpern
Circuit-based mechanisms mediating the development and execution of habitual behaviors involve complex cortical-striatal interactions that have been investigated in animal models and more recently in humans. However, how human brain circuits implicated in habit formation may be perturbed in psychiatric disorders remains unclear. First, we identified the locations of the sensorimotor putamen and associative caudate in the human brain using probabilistic tractography from Human Connectome Project data. We found that multivariate connectivity of the sensorimotor putamen was altered in humans with binge eating disorder and bulimia nervosa and that the degree of alteration correlated with severity of disordered eating behavior. Furthermore, the extent of this circuit aberration correlated with mean diffusivity in the sensorimotor putamen and decreased basal dopamine D2/3receptor binding potential in the striatum, consistent with previously reported microstructural changes and dopamine signaling mediating habit learning in animal models. Our findings suggest a neural circuit that links habit learning and binge eating behavior in humans, which could, in part, explain the treatment-resistant behavior common to eating disorders and other psychiatric conditions.

1 May 2024 in Stroke
Verified
Journal Article
Closed access
STSeth S Tigchelaar
Seth S Tigchelaar
AWAllan R. Wang
Allan R. Wang
SVSilvia D. Vaca
Silvia D. Vaca
YLYiping Li
Yiping Li
GSGary K. Steinberg
Gary K. Steinberg
BACKGROUND: Moyamoya disease (MMD) is a progressive, occlusive disease of the internal carotid arteries and their proximal branches, with the subsequent development of an abnormal vascular network that is rupture-prone. Steno-occlusive changes in the posterior cerebral arteries (PCAs) may contribute to worsened outcomes in patients with MMD; however, there is little information on the incidence and natural history of posterior circulation MMD (PCMMD). We describe clinical PCMMD characteristics in a large cohort of patients with MMD. METHODS: We retrospectively reviewed patients with MMD treated between 1991 and 2019 at a large academic medical center. Demographics, perioperative outcomes, and radiological phenotypes were recorded for 770 patients. PCA disease was graded as either 0 (no disease), 1 (mild), 2 (moderate), or 3 (severe or occluded) based on cerebral angiography. Patients with angiographically confirmed MMD diagnosis with at least 6 months follow-up and completion of revascularization surgery were included; patients with intracranial atherosclerosis, intracranial dissection, vasculitis, and undefined inflammatory processes were excluded. The presence of stenosis/occlusion was graded radiographically to assess for disease progression and the prevalence of risk factors related to reduced progression-free survival. RESULTS: In all, 686 patients met the inclusion criteria, with PCA disease identified in 282 (41.1%) patients. Of those 282 patients with PCMMD, disease severity ranged from 99 (35.1%) with mild, 72 (25.5%) with moderate, and 111 (39.4%) with severe. The total number of postoperative complications was significantly associated with PCMMD severity ( P =0.0067). Additionally, PCMMD severity correlated with worse postoperative modified Rankin Scale scores ( P <0.0001). At a mean follow-up of 6.0±3.9 (range, 0.1–25.0) years, a total of 60 (12.6%) patients showed new/worsening PCMMD. The overall postoperative, progression-free survival in patients with PCMMD was 95.4% at 1 year, 82.4% at 3 years, 68.8% at 5 years, and 28.3% at 10 years, with prognostic factors for progression including preoperative PCMMD status, history of tobacco use, and hypertension ( P <0.0001, P <0.001, and P <0.0001, respectively). CONCLUSIONS: PCA disease involvement in MMD is associated with higher rates of ischemic perioperative complications and worsened functional outcomes, likely due to reduced collateral flow. Ten-year progression of PCA disease is highly likely and should be monitored throughout follow-up; future studies will assess the impact of PCA disease progression on long-term outcomes.

1 August 2020 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
AWAllan R. Wang
Allan R. Wang
AGAlexa Groome
Alexa Groome
LTLara Taniguchi
Lara Taniguchi
NENeir Eshel
Neir Eshel
BBBrandon S. Bentzley
Brandon S. Bentzley
The role dopamine plays in reward-related behaviors has been debated for decades. Heymann et al. (Heymann G, Jo YS, Reichard KL, McFarland N, Chavkin C, Palmiter RD, Soden ME, Zweifel LS. Neuron 105: 909–920, 2020) identify subpopulations of dopamine-producing neurons that separately mediate reward association and motivation. Their results help demonstrate that dopamine signaling may partake in both reinforcement learning and incentive salience functions, instantiated by neuropeptide-defined subpopulations of the ventral tegmental area with different projection targets.